ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knight, J.
Right arrow Articles by Clayton, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knight, J.
Right arrow Articles by Clayton, F.
Annals of Clinical and Laboratory Science, Vol 26, Issue 4, 283-290
Copyright © 1996 by Association of Clinical Scientists


Articles

The effect of desferrioxamine on stored erythrocytes: lipid peroxidation, deformability, and morphology

JA Knight, DA Searles, and FC Clayton

Acid-citrate-dextrose (ACD) was introduced in 1947 as a nutrient-anticoagulant solution to preserve stored whole blood. A decade later, the introduction of citrate-phosphate-dextrose (CPD) resulted in the successful preservation of whole blood for 21 days. In 1978, added adenine and increased glucose concentration (CPDA-1) increased storage to 35 days. More recently, other solutions such as AS-1, further increased the acceptable storage time of packed cells, but cost and inconvenience have limited their use. Several recent studies have investigated the possibility of increasing the shelf-life of whole blood by the addition of various antioxidants. In the current study a comparison was made of the effects of the metal chelator desferrioxamine on several parameters of stored red cells. Thus, measurement was made of plasma malondialdehyde levels, a measure of lipid peroxidation, red cell filtration times, a measure of red cell deformability, and red cell morphology by electron microscopy. Our results showed that adding desferrioxamine significantly decreased levels of plasma malondialdehyde (MDA) and slowed the loss of erythrocyte deformability. Although red cell morphology suggested that the treated cells maintained their normal appearance longer than untreated cells, the differences were not statistically significant. These results suggest that the addition of desferrioxamine to CPDA-1 anticoagulated blood might be effective in prolonging the viability of stored erythrocytes.


This article has been cited by other articles:


Home page
PerfusionHome page
G. Trittenwein, A. T Rotta, B. Gunnarsson, and D. M Steinhorn
Lipid peroxidation during initiation of extracorporeal membrane oxygenation after hypoxia in endotoxemic rabbits
Perfusion, January 1, 1999; 14(1): 49 - 57.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Association of Clinical Scientists.